MedPath
HSA Approval

Poro Suspension 250mg/5ml

SIN13340P

Poro Suspension 250mg/5ml

Poro Suspension 250mg/5ml

August 27, 2007

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence HolderYUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

N02BE01

paracetamol

Manufacturer Information

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Y.S.P. Industries (M) Sdn Bhd

Active Ingredients

Paracetamol micronized

50.0 mg/ml

Acetaminophen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Poro Suspension 250mg/5ml - HSA Approval | MedPath